Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Christopher E. Walsh"'
Publikováno v:
BioTechniques, Vol 34, Iss 5, Pp 1074-1080 (2003)
Recombinant lentiviral vectors stably transduce both dividing and nondividing cells. Virus pseudotyping with vesicular stomatitis virus envelope G (VSV-G) protein broadens the host range of lentiviral vector and enables vector concentration by ultrac
Externí odkaz:
https://doaj.org/article/77ff9896e246443db4c314b37c097f0a
Autor:
Sarina Levy‐Mendelovich, Christopher E. Walsh, Jonathan M. Schapiro, Shelly Soffer, Eyal Klang, Gili Kenet
Publikováno v:
Haemophilia. 29:784-789
Autor:
Bruce Ewenstein, Maurus de la Rosa, Barbara A. Konkle, Ivan Bilic, Birgit M. Reipert, Paul E. Monahan, Scott W.J. McPhee, R. Jude Samulski, Hanspeter Rottensteiner, Miguel A. Escobar, Neil C. Josephson, John C. Chapin, Friedrich Scheiflinger, Annette von Drygalski, Guy Young, Christopher E. Walsh
Publikováno v:
Blood
Gene therapy has the potential to maintain therapeutic blood clotting factor IX (FIX) levels in patients with hemophilia B by delivering a functional human F9 gene into liver cells. This phase 1/2, open-label dose-escalation study investigated BAX 33
Autor:
Rachel Miller, Lisa N. Boggio, Lanette Brown-Jones, Hossam Saad, Kim Baumann, Michelle Witkop, Sarah Hawk, Mark W. Skinner, Kerry Hansen, Brittany Savage, Don Molter, Christopher E. Walsh, Stormy Johnson, Margaret Bradbury, Spencer Dunn, Kimberly Haugstad, David L. Cooper, Tammy Davenport
Publikováno v:
Haemophilia. 27:25-32
Introduction The experiences of patients with mild-to-moderate haemophilia differ from those of patients with severe haemophilia or those without a bleeding disorder and include a challenging diagnosis and variability in bleeding symptoms and treatme
Publikováno v:
Journal of Blood Medicine. 10:243-250
Autor:
Kenneth B Lewis, Richard J Hughes, Melinda S Epstein, Neil C Josephson, Christine L Kempton, Craig M Kessler, Nigel S Key, Tom E Howard, Rebecca Kruse-Jarres, Jeanne M Lusher, Christopher E Walsh, Raymond G Watts, Ruth A Ettinger, Kathleen P Pratt, PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e61120 (2013)
Evidence of antibody isotype/subtype switching may provide prognostic value regarding the state of immune responses to therapeutic proteins, e.g. anti-factor VIII (FVIII) antibodies that develop in many hemophilia A patients, clinically termed "inhib
Externí odkaz:
https://doaj.org/article/ed2b94404c024e57811b2da41995a2a6
Publikováno v:
Haemophilia, 26(6), e334-e336. Wiley-Blackwell
Haemophilia
Haemophilia
Autor:
Maissaa Janbain, Jacqueline N. Poston, Aric Parnes, Christopher E. Walsh, Lynn M. Malec, Craig M. Kessler, Kadhim Al-Banaa, Rebecca Kruse-Jarres, James F Wu, Annette von Drygalski
Publikováno v:
Blood. 138:496-496
Introduction Acquired hemophilia A (AHA) is a severe bleeding disorder due to autoantibodies against factor VIII (FVIII) with high morbidity/mortality from bleeding and complications from immunosuppression. Outcomes could improve with adequate hemost
Autor:
Judith A. Boice, James Bolognese, Nathaniel P. Katz, Mary Garfield, Mark Corrigon, Stacy E. Croteau, Kim Mauer, Robert F. Sidonio, Tyler W. Buckner, Christopher E. Walsh
Publikováno v:
Blood. 138:4243-4243
Background: Intra-articular bleeding (hemarthrosis) accounts for 80-90% (Roosendaal, et. al. Semin Thromb Hemost . 2003;29:37) of all bleeds and more than 90% of serious bleeding events in patients with severe hemophilia (Valentino. J Thromb Haemost
Autor:
Ellis J. Neufeld, Doris Quon, Paul Giangrande, Stephanie Seremetis, C. S. Hoxer, David L. Cooper, Neeraj N. Iyer, Christopher E. Walsh, L. Solimeno
Publikováno v:
Haemophilia. 23:821-831
Background While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce. Objective The aim of this study was to better understand perioperative m